Han F - Search Results

1

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis.

Lu L, Cai S, Zhu H, Liu G, Wang Y, Ren P, Lan L, Shen X, Chen L, Xu Y, Cheng J, Li X, Chen J, Han F. Lu L, et al. Among authors: han f. BMC Nephrol. 2024 Dec 24;25(1):473. doi: 10.1186/s12882-024-03912-4. BMC Nephrol. 2024. PMID: 39719585 Free PMC article.

2

Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis.

Lan L, Han F, Chen JH. Lan L, et al. Among authors: han f. J Zhejiang Univ Sci B. 2012 Sep;13(9):731-44. doi: 10.1631/jzus.B1200057. J Zhejiang Univ Sci B. 2012. PMID: 22949364 Free PMC article. Review.

3

The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.

Ren P, Han F, Chen L, Xu Y, Wang Y, Chen J. Ren P, et al. Among authors: han f. Am J Nephrol. 2012;36(3):271-7. doi: 10.1159/000341914. Epub 2012 Sep 7. Am J Nephrol. 2012. PMID: 22965140

4

The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study.

Ma Y, Han F, Chen L, Wang H, Han H, Yu B, Xu Y, Chen J. Ma Y, et al. Among authors: han h, han f. BMC Nephrol. 2017 Dec 29;18(1):381. doi: 10.1186/s12882-017-0782-4. BMC Nephrol. 2017. PMID: 29287586 Free PMC article.

5

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Zhang Q, Wang Y, Xu Y, Lan L, Chen J, Han F. Zhang Q, et al. Among authors: han f. Nephron. 2019;143(4):228-233. doi: 10.1159/000501857. Epub 2019 Aug 27. Nephron. 2019. PMID: 31454804

6

The correlation of anti-β2-glycoprotein I antibody with complement activation in patients with idiopathic membranous nephropathy.

Zhang Q, Wang Y, Ma Y, Jin L, Lan L, Ren P, Chen J, Han F. Zhang Q, et al. Among authors: han f. Int Urol Nephrol. 2021 May;53(5):955-959. doi: 10.1007/s11255-020-02698-2. Epub 2021 Jan 3. Int Urol Nephrol. 2021. PMID: 33392885 Clinical Trial.

7

Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.

Lan L, Lin Y, Yu B, Wang Y, Pan H, Wang H, Lou X, Lang X, Zhang Q, Jin L, Yang Y, Xiao L, Chen J, Han F. Lan L, et al. Among authors: han f. Am J Nephrol. 2024;55(1):25-36. doi: 10.1159/000535010. Epub 2023 Nov 14. Am J Nephrol. 2024. PMID: 37963441

8

Efficacy of rituximab for patients with anti-glomerular basement membrane disease.

Chen L, Chen Y, Ni A, Lin Y, Shen X, Chen J, Han F. Chen L, et al. Among authors: han f. Nephrol Dial Transplant. 2024 Mar 27;39(4):720-723. doi: 10.1093/ndt/gfad268. Nephrol Dial Transplant. 2024. PMID: 38130241 No abstract available.

9

Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab.

Lin Y, Pan Y, Han Q, Xu J, Wang J, Lei X, Chen L, Wang Y, Ren P, Lan L, Chen J, Han F. Lin Y, et al. Among authors: han q, han f. Am J Nephrol. 2024 Oct 11:1-10. doi: 10.1159/000541972. Online ahead of print. Am J Nephrol. 2024. PMID: 39396511

10

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J. Li X, et al. Among authors: han f. Am J Kidney Dis. 2009 Jul;54(1):51-8. doi: 10.1053/j.ajkd.2009.02.018. Epub 2009 May 5. Am J Kidney Dis. 2009. PMID: 19406543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,136 results

Search Page

Filters